Silencing of Long Non-coding RNA ENST00000606790.1 Inhibits the Malignant Behaviors of Papillary Thyroid Carcinoma through the PI3K/AKT Pathway

References

• Schmidbauer B, Menhart K, Hellwig D, Grosse J. Differentiated thyroid cancer-treatment: state of the art. Int J Mol Sci. 2017;18.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;2016(26):1–133.
   Google Scholar
• Caron NR, Clark OH. Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol. 2005;6:311–322. doi:10.1007/s11864-005-0035-9.
   PubMedGoogle Scholar
• Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg. 2005;71:731–734. doi:10.1177/000313480507100907.
   PubMed Web of Science ®Google Scholar
• Fatima R, Akhade VS, Pal D, Rao SM. Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets. Mol Cell Ther. 2015;3:5.
   PubMedGoogle Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253–1261. doi:10.1038/nm.3981.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang X, Li J, et al. Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. Mol Biosyst. 2015;11:760–769. doi:10.1039/C4MB00511B.
   PubMedGoogle Scholar
• Cai H, Yao J, An Y, et al. LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer. Oncotarget. 2017;8:32905–32917. doi:10.18632/oncotarget.16462.
   PubMedGoogle Scholar
• Luo Y, Ouyang J, Zhou D, et al. Long noncoding RNA GAPLINC promotes cells migration and invasion in colorectal cancer cell by regulating miR-34a/c-MET signal pathway. Dig Dis Sci. 2018;63:890–899. doi:10.1007/s10620-018-4915-9.
   PubMed Web of Science ®Google Scholar
• Lan X, Sun W, Zhang P, et al. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance. Tumour Biol. 2016;37:6117–6123. doi:10.1007/s13277-015-4461-4.
   PubMedGoogle Scholar
• Cai Y, Yan P, Zhang G, Yang W, Wang H, Cheng X. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFalpha. Cancer Biomarkers. 2018;23:145–156. doi:10.3233/CBM-181503.
   PubMed Web of Science ®Google Scholar
• Yang P, Chen T, Xu Z, Zhu H, Wang J, He Z. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO. Oncotarget. 2106;7(27):42183–42194. doi:10.18632/oncotarget.9741.
   Google Scholar
• Zhou W, Ye XL, Xu J, et al. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Sci Signal. 2017;10:eaak9557. doi:10.1126/scisignal.aak9557.
   PubMed Web of Science ®Google Scholar
• Ma L, Tian X, Wang F, et al. The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma. Cancer Biol Ther. 2016;17(10):1051–1061. doi:10.1080/15384047.2016.1219814.
   PubMed Web of Science ®Google Scholar
• Fan Y, Shen B, Tan M, et al. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014;281:1750–1758. doi:10.1111/febs.12737.
   PubMed Web of Science ®Google Scholar
• Qi Y, Ooi HS, Wu J, et al. MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10. Oncotarget. 2016;7:12693–12703. doi:10.18632/oncotarget.7281.
   PubMedGoogle Scholar
• Wang Y, Guo Q, Zhao Y, et al. BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma. Oncol Lett. 2014;8:1947–1952. doi:10.3892/ol.2014.2487.
   PubMed Web of Science ®Google Scholar
• Zhu H, Lv Z, An C, et al. Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma. Sci Rep. 2016;6:31969. doi:10.1038/srep31969.
   PubMed Web of Science ®Google Scholar
• Fang L, Sun J, Pan Z, et al. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IkappaB. Am J Physiol Gastrointest Liver Physiol. 2017;313:G150–G156. doi:10.1152/ajpgi.00426.2016.
   PubMed Web of Science ®Google Scholar
• Liao T, Qu N, Shi RL, et al. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer. Oncotarget. 2017;8:238–247. doi:10.18632/oncotarget.10825.
   PubMedGoogle Scholar
• Wang X, Lu X, Geng Z, Yang G, Shi Y. LncRNA PTCSC3/miR-574-5p governs cell proliferation and migration of papillary thyroid carcinoma via Wnt/beta-catenin signaling. J Cell Biochem. 2017;118:4745–4752. doi:10.1002/jcb.26142.
   PubMed Web of Science ®Google Scholar
• Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K/AKT signalling pathway and cancer. Gene. 2019;698:120–128. doi:10.1016/j.gene.2019.02.076.
   PubMed Web of Science ®Google Scholar
• Nozhat Z, Hedayati M. PI3K/AKT pathway and its mediators in thyroid carcinomas. Mol Diagn Ther. 2016;20:13–26. doi:10.1007/s40291-015-0175-y.
   PubMed Web of Science ®Google Scholar
• Derossi D, Williams EJ, Green PJ, Dunican DJ, Doherty P. Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. Biochem Biophys Res Commun. 1998;251:148–152. doi:10.1006/bbrc.1998.9444.
   PubMed Web of Science ®Google Scholar
• Ding L, Ding L, Wang S, et al. Tanshinone IIA affects autophagy and apoptosis of glioma cells by inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway. Pharmacology. 2017;99:188–195. doi:10.1159/000452340.
   PubMed Web of Science ®Google Scholar
• Turovsky EA, Turovskaya MV, Gaidin SG, Zinchenko VP. Cytokine IL-10, activators of PI3-kinase, agonists of alpha-2 adrenoreceptor and antioxidants prevent ischemia-induced cell death in rat hippocampal cultures. Arch Biochem Biophys. 2017;615:35–43. doi:10.1016/j.abb.2017.01.001.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhao L, Ji L, Bai L, Wen Q. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212. Biomed Pharmacother. 2019;118:109298. doi:10.1016/j.biopha.2019.109298.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang Z, Wang C, Ai Z. Long non-coding RNA MIAT promotes papillary thyroid cancer progression through upregulating LASP1. Cancer Cell Int. 2019;19:194. doi:10.1186/s12935-019-0913-z.
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965–3981. doi:10.1158/0008-5472.CAN-16-2634.
   PubMed Web of Science ®Google Scholar
• Jia H, Wang X, Sun Z. Exploring the long noncoding RNAs-based biomarkers and pathogenesis of malignant transformation from dysplasia to oral squamous cell carcinoma by bioinformatics method. Eur J Cancer Prev. 2019;29:174-181.
   Web of Science ®Google Scholar
• Cossu AM, Mosca L, Zappavigna S, et al. Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours. Int J Mol Sci. 2019:20.
   Web of Science ®Google Scholar
• Siddique H, Al-Ghafari A, Choudhry H, et al. Long noncoding RNAs as prognostic markers for colorectal cancer in Saudi patients. Genet Test Mol Biomarkers. 2019;23:509–514. doi:10.1089/gtmb.2018.0308.
   PubMed Web of Science ®Google Scholar
• Song L, Zhang S, Duan C, et al. Genome-wide identification of lncRNAs as novel prognosis biomarkers of glioma. J Cell Biochem. 2019;120:19518–19528. doi:10.1002/jcb.29259.
   PubMed Web of Science ®Google Scholar
• Lanz MC, Dibitetto D, Smolka MB. DNA damage kinase signaling: checkpoint and repair at 30 years. EMBO J. 2019;38:e101801.
   PubMed Web of Science ®Google Scholar
• Chen T, Stephens PA, Middleton FK, Curtin NJ. Targeting the S and G2 checkpoint to treat cancer. Drug Discov Today. 2012;17:194–202. doi:10.1016/j.drudis.2011.12.009.
   PubMed Web of Science ®Google Scholar
• Wang JN, Zhang ZR, Che Y, et al. Acetyl-macrocalin B, an ent-kaurane diterpenoid, initiates apoptosis through the ROS-p38-caspase 9-dependent pathway and induces G2/M phase arrest via the Chk1/2-Cdc25C-Cdc2/cyclin B axis in non-small cell lung cancer. Cancer Biol Ther. 2018;19:609–621. doi:10.1080/15384047.2018.1449613.
   PubMed Web of Science ®Google Scholar
• Sun WJ, Huang H, He B, et al. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells. Biochem Pharmacol. 2017;127:90–100.
   PubMed Web of Science ®Google Scholar
• Sanchez Y, Wong C, Thoma RS, et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science. 1997;277:1497–1501. doi:10.1126/science.277.5331.1497.
   PubMed Web of Science ®Google Scholar
• Hiraoka D, Aono R, Hanada S, Okumura E, Kishimoto T. Two new competing pathways establish the threshold for cyclin-B-Cdk1 activation at the meiotic G2/M transition. J Cell Sci. 2016;129:3153–3166. doi:10.1242/jcs.182170.
   PubMed Web of Science ®Google Scholar
• Manfredi GI, Dicitore A, Gaudenzi G, Caraglia M, Persani L, Vitale G. PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy. Endocrine. 2015;48:363–370. doi:10.1007/s12020-014-0380-1.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang Y, Xi S. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals. Artif Cells Nanomed Biotechnol. 2019;47:3043–3052. doi:10.1080/21691401.2019.1640233.
   PubMed Web of Science ®Google Scholar
• Wei L, Yi Z, Guo K, Long X. Long noncoding RNA BCAR4 promotes glioma cell proliferation via EGFR/PI3K/AKT signaling pathway. J Cell Physiol. 2019. doi:10.1002/jcp.28929.
   Google Scholar
• Liu JS, Huo CY, Cao HH, et al. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Phytomedicine. 2019;61:152843. doi:10.1016/j.phymed.2019.152843.
   PubMed Web of Science ®Google Scholar
• Lin W, Xie J, Xu N, et al. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells. Int J Biol Sci. 2018;14:418–426. doi:10.7150/ijbs.23602.
   PubMed Web of Science ®Google Scholar
• Li L, Wang X, Sharvan R, Gao J, Qu S. Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways. Biomed Pharmacother. 2017;95:1225–1231. doi:10.1016/j.biopha.2017.09.010.
   PubMed Web of Science ®Google Scholar
• Ye K, Li J, Li X, Chang S, Zhang Z. Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway. Oncol Lett. 2018;15:1313–1318. doi:10.3892/ol.2017.7367.
   PubMedGoogle Scholar
• Zheng Z, Zhou X, Cai Y, et al. TEKT4 promotes papillary thyroid cancer cell proliferation, colony formation, and metastasis through activating PI3K/Akt pathway. Endocr Pathol. 2018;29:310–316. doi:10.1007/s12022-018-9549-0.
   PubMed Web of Science ®Google Scholar